The Antinuclear Antibody Test Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for the global antinuclear antibody test has experienced significant growth recently. It is projected to increase from $1.54 billion in 2024 to $1.74 billion in 2025, with a compound annual growth rate (CAGR) of 12.9%.
The Antinuclear Antibody Test Global Market Report 2025 projects that by 2029, the market size will reach $2.79 billion with a compound annual growth rate (CAGR) of 12.6%.
Download Your Free Sample of the 2025 Antinuclear Antibody Test Market Report and Uncover Key Trends Now!The key drivers in the antinuclear antibody test market are:
• Rising incidence of autoimmune disorders
• Technological advancements in diagnostic tools
• Growing focus on personalized medicine
• Increasing healthcare infrastructure in developing regions
The antinuclear antibody test market covered in this report is segmented –
1) By Product: Assay Kits, Reagent Kits, Software And Services
2) By Technology: Immunofluorescence Assay, Multiplex Assay, ELISA
3) By Application: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications
4) By End-User: Hospitals, Clinical, Physician Laboratories
Subsegments:
1) By Assay Kits: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Immunofluorescence Assay (IFA) Kits, Western Blot Assay Kits
2) By Reagent Kits: Antigen Reagents, Conjugated Antibodies, Detection Reagents
3) By Software And Services: Data Management Software, Laboratory Information Management Systems (LIMS), Technical Support And Consulting Services
The key trends in the antinuclear antibody test market are:
• The integration of artificial intelligence in diagnostics is shaping the future of the market.
• The development and utilization of point-of-care testing devices is an emerging trend.
• The market is seeing a trend towards the adoption of multiplex testing technologies.
• There is an increase in the use of machine learning for data analysis and improvements in automation and high-throughput testing systems.
Major players in the antinuclear antibody test market are:
• Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• LabCorp
• Quest Diagnostics Incorporated
• Grifols SA
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Werfen SA
• DiaSorin SpA
• EUROIMMUN AG
• Abcam plc
• Trinity Biotech plc
• Zeus Scientific Inc.
• ERBA Diagnostics Inc.
• Quidel Corporation
• Antibodies Incorporated
• Immuno Concepts Inc.
• Inova Diagnostics
North America was the largest region in the antinuclear antibody test market in 2024